Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Hameenlinna

4 clinical trials in Hameenlinna, Finland. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Hameenlinna at a glance
4
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Hameenlinna

Open in trial search
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:HUS-yhtymae
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Vigabatrin
  • Sponsor:HUS-yhtymae
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Hameenlinna

What the registry says about research in the country

01 Pediatric Neurology

Groundbreaking research focusing on the prevention of infantile spasms in high-risk infants under one year of age. The studies investigate preventive approaches using vigabatrin prophylactic treatment.

  • Tuberous Sclerosis
  • Vascular Cortical Injuries
  • Intraventricular Hemorrhage
  • Periventricular Leukomalacia

This research aims to advance early intervention strategies for neurological conditions in infants, potentially transforming the standard of care for high-risk pediatric patients.

02 Neurological Prevention

Clinical trials examining preventive measures for seizure disorders in vulnerable infant populations, with a particular focus on those with brain structural abnormalities.

  • Brain Hemorrhage Management
  • Cortical Injury Treatment
  • Hypoxic-Ischemic Encephalopathy

The research explores innovative prophylactic approaches to prevent the onset of serious neurological complications in at-risk infants.

03 Early Intervention Studies

Focused research on preventive treatments for infants with identified risk factors for developing neurological complications.

  • Prophylactic Medication Studies
  • Risk Factor Assessment
  • Preventive Care Protocols

These trials aim to establish effective preventive protocols for infants at high risk of developing serious neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.